Showing 1471-1480 of 1564 results for "".
- Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patientshttps://modernod.com/news/results-from-first-clinical-study-using-danoprevir-to-treat-naive-and-experienced-covid-19-patients/2477455/Ascletis Pharma announced the first clinical study using Ganovo (danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv. The data from this small-sample clinical study showed that danoprevir combined with ritonavir is safe and well tolerated in all p
- FDA Authorizes Hand-Held COVID-19 Diagnostic Testhttps://modernod.com/news/fda-authorizes-hand-held-covid-19-diagnostic-test/2477452/In response to the coronavirus crisis, we’ve seen COVID-19 diagnostics quickly evolve from early, multistep kits to high-throughput versions to fast point-of-care tests, all in just a few weeks. Now, the FDA has granted an emergency authorization to a device that fits in the palm of you
- Arnold & Porter to Host Webinar on Proposed CARES Acthttps://modernod.com/news/arnold-porter-to-host-webinar-on-proposed-cares-act/2477437/The coronavirus has swept across the United States, paralyzing much of the nation, ending a record run on Wall Street, and inducing a level of economic uncertainty and anxiety that threatens to plunge us all into a global recession or depression. The resulting crisis has created unprecedented eme
- President of Glaucoma Research Foundation Issues Messagehttps://modernod.com/news/president-of-glaucoma-research-foundation-issues-message/2477429/The Glaucoma Research Foundation sent an email to its membership on Friday, answering questions that glaucoma specialists may have during the COVID-19 pandemic. The letter reads: Dear Friends, Your health and well-being are on our minds as we all deal with a national and glob
- President Invokes the Defense Production Act in Response to COVID-19https://modernod.com/news/president-invokes-the-defense-production-act-in-response-to-covid-19/2477413/The President and the Secretary of Health and Human Services (HHS) reportedly plan to invoke the Defense Production Act of 1950 (DPA) to support the COVID-19 response by giving the federal government priority over all other customers for items such as masks and ventilators, according to an Arnold
- CMS Recommends Limit on Nonessential Planned Surgeries, Including Postponement of Cataract Procedureshttps://modernod.com/news/cms-recommends-limit-on-nonessential-planned-surgeries-including-postponement-of-cataract-procedures/2477414/On March 18, CMS issued a series of recommendations regarding the furnishing of all nonessential planned surgeries and procedures based on the need to conserve critical resources, such as ventilators and personal protective equipment, and limiting exposure of patients and staff to COVID-19, accor
- EyeTech Launches EyeOn Ultra-Compact Eye-Tracking Tablet Platformhttps://modernod.com/news/eyetech-launches-eyeon-ultra-compact-eye-tracking-tablet-platform/2477269/EyeTech Digital Systems announced the launch of EyeOn, an all-in-one, ultra-slim eye gaze tablet during this year’s Assistive Technology Industry Association conference in Orlando. The EyeOn eye tracking platform enables people with mobility and motor impairments to select, type, and speak entire
- Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for DR and DME from Apexian Pharmaceuticalshttps://modernod.com/news/ocuphire-pharma-announces-in-license-of-phase-2-oral-small-molecule-drug-candidate-for-dr-and-dme-from-apexian-pharmaceuticals/2477254/Ocuphire Pharma announced that it has entered into an agreement with Apexian Pharmaceuticals, granting Ocuphire an exclusive worldwide sublicense to Apexian’s Ref-1 Inhibitor program, including its lead drug candidate APX3330, for all ophthalmic and diabetic indications. APX3330 is a first
- New Analysis Expands on Link Between Pharma Payments, Prescribinghttps://modernod.com/news/new-analysis-expands-on-link-between-pharma-payments-prescribing/2477201/Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties, a new ProPublica analysis found. The pattern is consistent for almost all of the most widely pr
- AOA: Changes on the Horizon for Evaluation and Management Serviceshttps://modernod.com/news/aoa-changes-on-the-horizon-for-evaluation-and-management-services/2477202/There has been a lot of information disseminated by various individuals and organizations regarding upcoming changes to coding and reimbursement for evaluation and management services (E/M services). Given the importance of E/M services in patient care, it’s critical that all doctors of opt